Phase I-II study of high-dose etoposide in patients with refractory breast cancer

Invest New Drugs. 1991 Nov;9(4):365-7. doi: 10.1007/BF00183583.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Drug Evaluation
  • Etoposide / administration & dosage*
  • Etoposide / adverse effects
  • Female
  • Humans

Substances

  • Etoposide